CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) -- BioAro, a leading precision health and genomics company, is proud to announce a groundbreaking achievement in the field of Whole Genome Sequencing (WGS). Using the cutting-edge AI-powered platform, BioAro’s laboratory has successfully processed a WGS sample provided by the and received a in variant calling (identifying genetic differences) - an accomplishment that is difficult in genomic science.
Whole Genome Sequencing is a powerful tool in precision medicine, but the complexity of the human genome and differences in sequencing technologies and bioinformatics pipelines make achieving a 100% match in variant calls between laboratories extremely difficult. Studies have shown that even with the most advanced technologies, match rates typically range between 95-98%, making a 100% match highly unlikely. achievement is a significant milestone in overcoming these challenges.
This breakthrough was made possible by leveraging the PanOmiQ platform, a revolutionary technology that integrates advanced machine learning algorithms, real-time data sharing, and standardized bioinformatics pipelines to deliver unparalleled accuracy in genomic analysis. PanOmiQ’s ability to standardize processes across different labs ensures consistency and reliability in variant calling, a crucial factor in achieving the rare 100% match. , commented, This accomplishment is a testament to the power of innovation and collaboration.
PanOmiQ has enabled us .